Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Serra

Showing results (91-100 of 154) with videos related to

Pageof 16
Sort By:
Cancer Medicine|February 24, 2018
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG miceMaria Eugenia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, et al.
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
International Journal of Molecular Sciences|November 23, 2018
Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of OsteosarcomaElisa Martella, Claudia Ferroni, Andrea Guerrini, et al.
Cancers|April 3, 2021
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific DeliveryElia Bari, Massimo Serra, Mayra Paolillo, et al.
Analytica Chimica Acta|December 21, 2010
Screening of fibrillogenesis inhibitors of β2-microglobulin: integrated strategies by mass spectrometry capillary electrophoresis and in silico simulationsLuca Regazzoni, Raffaella Colombo, Laura Bertoletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cellsKatia Scotlandi, Stefania Perdichizzi, Maria Cristina Manara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremitiesMassimo Serra, Katia Scotlandi, Gemma Reverter-Branchat, et al.
Cancer Gene Therapy|March 16, 2002
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cellsKatia Scotlandi, Cecilia Maini, Maria Cristina Manara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcomeKatia Scotlandi, Daniel Remondini, Gastone Castellani, et al.
Genes, Chromosomes & Cancer|October 29, 2009
Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization studyTarja Niini, José Antonio López-Guerrero, Shinsuke Ninomiya, et al.
Pageof 16

Showing results (91-100 of 154) with videos related to

Sort By:
Pageof 16
Cancer Medicine|February 24, 2018
Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG miceMaria Eugenia Marques da Costa, Estelle Daudigeos-Dubus, Anne Gomez-Brouchet, et al.
International Journal of Cancer|September 5, 2002
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cellsKatia Scotlandi, Sofia Avnet, Stefania Benini, et al.
International Journal of Molecular Sciences|November 23, 2018
Functionalized Keratin as Nanotechnology-Based Drug Delivery System for the Pharmacological Treatment of OsteosarcomaElisa Martella, Claudia Ferroni, Andrea Guerrini, et al.
Cancers|April 3, 2021
Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific DeliveryElia Bari, Massimo Serra, Mayra Paolillo, et al.
Analytica Chimica Acta|December 21, 2010
Screening of fibrillogenesis inhibitors of β2-microglobulin: integrated strategies by mass spectrometry capillary electrophoresis and in silico simulationsLuca Regazzoni, Raffaella Colombo, Laura Bertoletti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 11, 2002
Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cellsKatia Scotlandi, Stefania Perdichizzi, Maria Cristina Manara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Value of P-glycoprotein and clinicopathologic factors as the basis for new treatment strategies in high-grade osteosarcoma of the extremitiesMassimo Serra, Katia Scotlandi, Gemma Reverter-Branchat, et al.
Cancer Gene Therapy|March 16, 2002
Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cellsKatia Scotlandi, Cecilia Maini, Maria Cristina Manara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2009
Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcomeKatia Scotlandi, Daniel Remondini, Gastone Castellani, et al.
Genes, Chromosomes & Cancer|October 29, 2009
Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization studyTarja Niini, José Antonio López-Guerrero, Shinsuke Ninomiya, et al.
Pageof 16